1-氰基-2-苯基乙铵氯化物 | 93554-83-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-氰基-2-苯基乙铵氯化物
• 中文别名: 2-氨基-3-苯基丙腈盐酸盐
• 英文名称: α-aminophenylpropiononitrile hydrochloride
• 英文别名: DL-phenylalanine nitrile hydrochloride；DL-Phenylalanin-nitril; Hydrochlorid；rac-2-amino-3-phenylpropionitrile hydrochloride；alpha-benzyl-alpha-aminoacetonitrile hydrochloride；(R/S)-2-amino-3-phenylpropanenitrile hydrochloride；2-amino-3-phenylpropanenitrile hydrochloride；2-amino-3-phenylpropanenitrile;hydrochloride
• CAS: 93554-83-7
• 化学式: C₉H₁₀N₂*ClH
• mdl: MFCD00082676
• 分子量: 182.653
• InChiKey: ZMLFFOLHKSAFBV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.14
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  51.4
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2926909090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Amino-3-phenylpropanenitrile, HCl
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Amino-3-phenylpropanenitrile, HCl
CAS number: 93554-83-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H10N2.ClH
Molecular weight: 182.7

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-氰基-2-苯基乙铵氯化物 在 Raney nickel W₂ 吡啶 、 盐酸 、 氢气 、 四氯化钛 作用下， 以 乙醇 为溶剂， 反应 99.5h， 生成 2-tert-butyl-6-(p-methoxyphenyl)-8-benzyl-3,7-dihydroimidazo<1,2-a>pyrazin-3-one
  参考文献：
  名称：

  腔肠萤光素荧光素类似物的低温光氧化和1,2-二氧杂环丁酮作为发光中间体的证明

  摘要：

  在2-位具有叔丁基的腔肠荧光素类似物适合在各种条件下进行化学发光研究。在低温（-78°C）下对类似物进行光氧化可得到发光中间体，该发光中间体通过用PPh 3还原而被证明是过氧化物，从而导致发光能力下降。为了通过13 C NMR阐明这些积累的发光中间体的结构，在3,7-二氢咪唑并[1,2-a]吡嗪-3-酮的2、3和5位合成了三个13 C富集的类似物。骨架具有99％的富集和位点特异性。这13个将富C的腔肠荧光素类似物在-78°C进行光氧化，以形成两种过氧化物产物，作为发光中间体。这些不稳定的中间体的结构用的手段推断13 C NMR光谱在使用在三个位点被富集的底物低的温度13 ℃。在光氧化CF的混合物3 CD 2 OD和CD 3 OD为高度的质子溶剂，得到dioxetanone和2 -氢过氧化物。在含有酸或碱的二甘醇二甲醚（DGM）中稀释到10 -5 M后，这两种过氧化物在不同的温度下分别在400

  DOI：

  10.1016/0040-4020(96)00699-0
• 作为产物：
  描述：

  苯乙醛 在 氨 、 zinc(II) iodide 作用下， 以 甲醇 为溶剂， 反应 2.25h， 生成 1-氰基-2-苯基乙铵氯化物
  参考文献：
  名称：

  Facile synthesis of α-aminonitriles

  摘要：

  DOI：

  10.1016/s0040-4039(01)91205-5

文献信息

• Peptide ligation by chemoselective aminonitrile coupling in water
  作者：Pierre Canavelli、Saidul Islam、Matthew W. Powner

  DOI：10.1038/s41586-019-1371-4

  日期：2019.7

  N-to-C peptide ligation. Our model unites prebiotic aminonitrile synthesis and biological α-peptides, suggesting that short N-acyl peptide nitriles were plausible substrates during early evolution.Prebiotic peptide formation is achieved through chemoselective, high-yielding ligation of α-aminonitriles in water, showing selectivity for α-peptide coupling and tolerance of all proteinogenic amino acid residues

  酰胺键的形成是化学和生物学中最重要的反应之一 1-4，但目前还没有化学方法可以在水中实现 α-肽连接，从而耐受肽连接位点的所有 20 种蛋白质氨基酸。通用遗传密码确立了肽的生物学作用早于生命最后一个普遍的共同祖先，并且肽在生命起源中发挥了重要作用5-9。硫在柠檬酸循环、非核糖体肽合成和聚酮化合物生物合成中的重要作用指向在生命进化过程中，硫酯依赖性肽连接先于 RNA 依赖性蛋白质合成 5,9-13。然而，尚未证明氨酰基硫酯形成的稳健机制。在这里，我们报告了一种化学选择性，高产 α-氨基腈连接，仅利用益生元合理的分子——硫化氢、硫代乙酸盐 12,14 和铁氰化物 12,14-17 或氰基乙炔 8,14——在水中产生 α-肽。这种连接对 α-氨基腈偶联具有极高的选择性，并能耐受所有 20 个蛋白质氨基酸残基。两个基本特征使肽能够在水中连接：α-氨基腈的反应性和 pKaH 使它们与中性 pH 值的
• Heterocycles as masked diamide/dipeptide equivalents. Formation and reactions of substituted 5-(acylamino)oxazoles as intermediates en route to the cyclopeptide alkaloids
  作者：Bruce H. Lipshutz、Randall W. Hungate、Keith E. McCarthy

  DOI：10.1021/ja00364a041

  日期：1983.12

  Etude de la synthese de dialkyl-2,4 acylamino-5 oxazoles par cyclisation a partir d'α-cyanoalkylamides d'acides, de N-acetyl α-aminoamides ou de dipeptides. Fonctionnalisation des oxazoles obtenus

  从二烷基-2,4 酰基氨基-5 恶唑环化到部分 d'α-氰基烷基酰胺 d'酸、去 N-乙酰 α-氨基酰胺或二肽合成练习曲。钝性恶唑功能化
• [EN] 4 - (5 - ISOXAZOLYL OR 5 - PYRRAZOLYL -1,2,4- OXADIAZOL - 3 - YL) -MANDELIC ACID AMIDES AS SPHINGOSIN- 1 - PHOSPHATE 1 RRECEPTOR AGONISTS<br/>[FR] AMIDES D'ACIDE 4-(5-ISOXAZOLYL OU 5-PYRAZOLYL-1,2,4-OXADIAZOL-3-YL)-MANDÉLIQUE COMME AGONISTES DU RÉCEPTEUR DE LA SPHINGOSINE-1-PHOSPHATE DE TYPE 1
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2011133734A1

  公开（公告）日：2011-10-27

  Disclosed are compounds of Formula (I) or stereoisomers, salts, or prodrugs thereof, wherein: Q is, or R1 is phenyl substituted with zero to 3 substituents; and R1, R2, R3, R4, R5, and G are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.

  揭示了Formula (I)的化合物或其立体异构体、盐或前药，其中：Q是，或者R1是苯基，其上取代基为零至3个；而R1、R2、R3、R4、R5和G在此处有定义。还揭示了将这些化合物用作G蛋白偶联受体S1P1的选择性激动剂的方法，以及包含这些化合物的药物组合物。这些化合物在治疗、预防或减缓多种治疗领域的疾病或紊乱方面具有用处，如自身免疫疾病和血管疾病。
• Synthesis of α-Aryl Esters and Nitriles: Deaminative Coupling of α-Aminoesters and α-Aminoacetonitriles with Arylboronic Acids
  作者：Guojiao Wu、Yifan Deng、Chaoqiang Wu、Yan Zhang、Jianbo Wang

  DOI：10.1002/anie.201406765

  日期：2014.9.22

  Transition‐metal‐free synthesis of α‐aryl esters and nitriles using arylboronic acids with α‐aminoesters and α‐aminoacetonitriles, respectively, as the starting materials has been developed. The reaction represents a rare case of converting C(sp3)N bonds into C(sp3)C(sp2) bonds. The reaction conditions are mild, demonstrate good functional‐group tolerance, and can be scaled up.

  已开发出分别使用芳基硼酸与α-氨基酯和α-氨基乙腈作为原料的无过渡金属合成α-芳基酯和腈的方法。该反应代表了将C（sp 3）N键转换为C（sp 3）C（sp 2）键的罕见情况。反应条件温和，表现出良好的官能团耐受性，并且可以扩大规模。
• Process for the preparation of enantiomerically enriched compounds
  申请人：DSM IP Assets B.V.

  公开号：EP1352894A1

  公开（公告）日：2003-10-15

  1. Process for the preparation of enantiomerically enriched amino aldehydes and amino alcohols, wherein a corresponding enantiomerically enriched amino nitrile is subjected to hydrogenation in the presence of hydrogen, a hydrogenation catalyst, preferably a Pd-catalyst and a mineral acid. For the preparation of an amino aldehyde hydrogen preferably is present at a hydrogen-pressure between 0.1 and 2 MPa, in particular between 0.5 and 1 MPa. The amino aldehyde preferably is isolated in the form of a chemically and configurationally stable derivative. For the preparation of an amino alcohol, preferably at least during part of the hydrogenation hydrogen is present at a hydrogen-pressure between 2 and 10 MPa, in particular between 4 and 6 MPa. In a preferred embodiment the hydrogen-pressure initially is between 0,5 and 2 MPa and subsequently, after most of the nitrile starting material is converted, the hydrogen pressure is increased to a value between 2 and 10 MPa. The enantiomerically enriched nitrile starting material may a.o. be prepared by enzymatic resolution, classical resolution, resolution via preferential crystallization, diastereomeric synthesis, catalytic asymmetric synthesis or dehydratation of amino acid amides.

  制备对映富集的氨基醛和氨基醇的过程，其中对应的对映富集的氨基腈在氢气、氢化催化剂（最好是Pd催化剂）和矿酸存在下进行加氢。用于制备氨基醛时，最好在氢压力在0.1至2兆帕之间，特别是在0.5至1兆帕之间。氨基醛最好以化学和构型稳定的衍生物形式分离。用于制备氨基醇时，最好在加氢的部分时间内氢气的压力在2至10兆帕之间，特别是在4至6兆帕之间。在一种首选实施方式中，氢气压力最初在0.5至2兆帕之间，随后，在大部分腈起始物质被转化后，氢气压力增加到2至10兆帕之间的值。对映富集的腈起始物质可以通过酶解、经典分离、通过优先结晶分离、对映异构合成、催化不对称合成或氨基酸酰胺的脱水制备等方法制备。